Entrada Therapeutics, Inc. (TRDA) Form 8-K Material Events
Entrada Therapeutics, Inc. (TRDA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: TRDA
CIK: 1689375
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerZachary Parker
Audit LocationBoston, Massachusetts, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-14 | 2026-10-14 | 8-K | 0001689375-26-000057 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-10 | — | SCHEDULE 13D/A Filing | 0001231919-26-001160 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | 4 Filing | 0001231919-26-001156 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-04 | 4 Filing | 0001231919-26-001155 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001231919-26-001144 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-01 | 4 Filing | 0001231919-26-001143 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001613084-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001873392-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001873394-26-000005 | View SEC Doc Filr Page |
| 4 | 2026-09-03 | 2026-09-02 | FORM 4 | 0001725663-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | 4 Filing | 0001231919-26-001136 | View SEC Doc Filr Page |
| 4 | 2026-08-31 | 2026-08-27 | 4 Filing | 0001231919-26-001135 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 Filing | 0001231919-26-001107 | View SEC Doc Filr Page |
| 4 | 2026-08-26 | 2026-08-24 | 4 Filing | 0001231919-26-001106 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001193125-26-352315 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001664281-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-10 | 2026-08-06 | 4 Filing | 0001231919-26-000854 | View SEC Doc Filr Page |
| 144/A | 2026-08-10 | — | 144/A Filing | 0001674324-26-000008 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001689375-26-000054 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001689375-26-000052 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 Filing | 0001231919-26-000822 | View SEC Doc Filr Page |
| 4 | 2026-08-03 | 2026-07-30 | 4 Filing | 0001664281-26-000002 | View SEC Doc Filr Page |
| 144 | 2026-07-30 | — | 144 Filing | 0001674324-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001689375-26-000047 | View SEC Doc Filr Page |
| 4 | 2026-06-12 | 2026-06-10 | FORM 4 | 0001689375-26-000044 | View SEC Doc Filr Page |